13. Inflammation as target in treatment of depression in CHD patients: Evidence from an in vitro study von Nikkheslat, N, Zunszain, P.A, Tylee, A.T, Carvalho, L.A, Pariante, C.M

Volltext

P.2.a.035 Persistence with hypnotics in depressed patients treated in UK primary care von Gallagher, A.M, De Vries, F, Donoghue, J, Nutt, D.J, Tylee, A.T, Cockle, S.M, van Staa, T.P, Lader, M.H

Volltext

P.2.a.032 Resource use in depressed patients with sleep disturbance von Gallagher, A.M, De Vries, F, Nutt, D.J, Donoghue, J, Tylee, A.T, Cockle, S.M, van Staa, T.P, Lader, M.H

Volltext

P.2.a.034 The risk of suicide and suicidal ideation in depressed patients with sleep disturbance von Gallagher, A.M, De Vries, F, Tylee, A.T, Lader, M.H, Donoghue, J, Cockle, S.M, van Staa, T.P, Nutt, D.J

Volltext

P.2.a.033 Initiation of hypnotics or anxiolytics in depressed patients treated in UK primary care von Gallagher, A.M, De Vries, F, Nutt, D.J, Donoghue, J, Tylee, A.T, Cockle, S.M, van Staa, T.P, Lader, M.H

Volltext

P.2.a.021 Insomnia as a predictor of depression in UK primary care von de Vries, F, Gallagher, A.M, Lader, M.H, Tylee, A.T, Donoghue, J, Cockle, S.M, van Staa, T.P, Nutt, D.J

Volltext